128 related articles for article (PubMed ID: 20398005)
1. Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes.
Montagna P; Soldano S; Brizzolara R; Villaggio B; Triolo P; Clerico P; Meroni M; Sulli A; Seriolo B; Molfetta L; Cutolo M
Ann N Y Acad Sci; 2010 Apr; 1193():30-5. PubMed ID: 20398005
[TBL] [Abstract][Full Text] [Related]
2. Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients.
Cutolo M; Montagna P; Brizzolara R; Sulli A; Seriolo B; Villaggio B; Triolo P; Clerico P; Soldano S
J Autoimmun; 2009; 32(3-4):254-60. PubMed ID: 19324522
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis.
Cutolo M; Sulli A; Ghiorzo P; Pizzorni C; Craviotto C; Villaggio B
Ann Rheum Dis; 2003 Apr; 62(4):297-302. PubMed ID: 12634225
[TBL] [Abstract][Full Text] [Related]
4. The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function.
Kirsch BM; Zeyda M; Stuhlmeier K; Grisar J; Smolen JS; Watschinger B; Stulnig TM; Hörl WH; Zlabinger GJ; Säemann MD
Arthritis Res Ther; 2005; 7(3):R694-703. PubMed ID: 15899055
[TBL] [Abstract][Full Text] [Related]
5. Sex hormones and leflunomide treatment of human macrophage cultures: effects on apoptosis.
Montagna P; Brizzolara R; Soldano S; Pizzorni C; Sulli A; Cutolo M
Int J Clin Exp Med; 2009 Aug; 2(3):221-32. PubMed ID: 19918315
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients.
Cutolo M; Capellino S; Montagna P; Sulli A; Seriolo B; Villaggio B
Ann Rheum Dis; 2006 Jun; 65(6):728-35. PubMed ID: 16269423
[TBL] [Abstract][Full Text] [Related]
7. 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages.
Villaggio B; Soldano S; Cutolo M
Clin Exp Rheumatol; 2012; 30(6):934-8. PubMed ID: 23253631
[TBL] [Abstract][Full Text] [Related]
8. Effects of the active metabolite of leflunomide, A77 1726, on cytokine release and the MAPK signalling pathway in human rheumatoid arthritis synoviocytes.
Vergne-Salle P; Léger DY; Bertin P; Trèves R; Beneytout JL; Liagre B
Cytokine; 2005 Sep; 31(5):335-48. PubMed ID: 16099671
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of pro- and anti-inflammatory cytokine receptors by N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxy-crotonic acid amide (A77 1726), the physiologically active metabolite of the novel immunomodulator leflunomide.
Mirmohammadsadegh A; Homey B; Abts HF; Köhrer K; Ruzicka T; Michel G
Biochem Pharmacol; 1998 May; 55(9):1523-9. PubMed ID: 10076546
[TBL] [Abstract][Full Text] [Related]
10. [Effects of leflunomide and its active metabolite on the production and mRNA expression of TNF-alpha in peritoneal macrophages and synovial cells with adjuvant arthritis in rats].
Li WD; Lin ZB
Yao Xue Xue Bao; 2002 Oct; 37(10):767-70. PubMed ID: 12567858
[TBL] [Abstract][Full Text] [Related]
11. CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production.
Cutolo M; Soldano S; Montagna P; Sulli A; Seriolo B; Villaggio B; Triolo P; Clerico P; Felli L; Brizzolara R
Arthritis Res Ther; 2009; 11(6):R176. PubMed ID: 19930661
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting effects of Leflunomide metabolite on overexpression of CD147, MMP-2 and MMP-9 in PMA differentiated THP-1 cells.
Huang JL; Wu SY; Xie XJ; Wang MX; Zhu S; Gu JR
Eur J Pharmacol; 2011 Nov; 670(1):304-10. PubMed ID: 21871883
[TBL] [Abstract][Full Text] [Related]
13. A77 1726 induces differentiation of human myeloid leukemia K562 cells by depletion of intracellular CTP pools.
Huang M; Wang Y; Collins M; Mitchell BS; Graves LM
Mol Pharmacol; 2002 Sep; 62(3):463-72. PubMed ID: 12181422
[TBL] [Abstract][Full Text] [Related]
14. Leflunomide inhibits cytokine-induced DNA synthesis of rabbit synovial cells in culture.
Ju DW; Zheng QY; Wang HB; Fang J
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):223-6. PubMed ID: 7976375
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis.
Kraan MC; Smeets TJ; van Loon MJ; Breedveld FC; Dijkmans BA; Tak PP
Ann Rheum Dis; 2004 Sep; 63(9):1056-61. PubMed ID: 15115713
[TBL] [Abstract][Full Text] [Related]
17. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages.
Kramer PR; Kramer SF; Guan G
Arthritis Rheum; 2004 Jun; 50(6):1967-75. PubMed ID: 15188374
[TBL] [Abstract][Full Text] [Related]
18. The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes.
Palmer G; Burger D; Mezin F; Magne D; Gabay C; Dayer JM; Guerne PA
Arthritis Res Ther; 2004; 6(3):R181-9. PubMed ID: 15142263
[TBL] [Abstract][Full Text] [Related]
19. The active metabolite of leflunomide, A77 1726, increases proliferation of human synovial fibroblasts in presence of IL-1beta and TNF-alpha.
Magne D; Mézin F; Palmer G; Guerne PA
Inflamm Res; 2006 Nov; 55(11):469-75. PubMed ID: 17122964
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
Jang CH; Choi JH; Byun MS; Jue DM
Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
